A CDKN2A (p16) Mutation AssociatedWith Familial Pancreatic Cancer Reduces Protein Stability and Functionality

被引：0
|
作者：
Horn, I. P. [1 ]
Marks, D. L. [1 ]
Hogenson, T. L. [1 ]
Almada, L. L. [1 ]
Goldstein, L. E. [1 ]
Duran, P. A. Romecin [1 ]
Vrabel, A. M. [1 ]
Cui, G. [2 ]
Chaffee, K. G. [3 ]
Bamlet, W. R. [3 ]
Mer, G. [2 ]
Li, H. [4 ]
Petersen, G. M. [5 ]
Fernandez-Zapico, M. E. [1 ]
机构：
[1] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN USA
[2] Mayo Clin, Div Biochem & Mol Biol, Rochester, MN USA
[3] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
[4] Mayo Clin, Div Mol Pharmacol & Expt Therapeut, Rochester, MN USA
[5] Mayo Clin, Div Epidemiol, Rochester, MN USA
来源：
PANCREAS | 2018年 / 47卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1393 / 1394
页数：2
相关论文
共 50 条
  • [31] Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients
    Lukowsky, Ansgar
    Schaefer-Hesterberg, Gregor
    Sterry, Wolfram
    Voit, Christiane
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 49 (02) : 163 - 165
  • [32] Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
    Goldstein, AM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 230 - 230
  • [33] CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients
    Bradly, Dawn P.
    Gattuso, Paolo
    Pool, Mark
    Basu, Sanjib
    Liptay, Michael
    Bonomi, Philip
    Buckingham, Lela
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (04) : 207 - 213
  • [34] Homozygous deletion of CDKN2A (p16/p14) in neuroblastomas.
    Thompson, PM
    Maris, JM
    Hogarty, MD
    Seeger, RC
    Reynolds, CP
    Brodeur, GM
    White, PS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A327 - A327
  • [35] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    Schmidt, EE
    Ichimura, K
    Messerle, KR
    Goike, HM
    Collins, VP
    BRITISH JOURNAL OF CANCER, 1997, 75 (01) : 2 - 8
  • [36] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    EE Schmidt
    K Ichimura
    KR Messerle
    HM Goike
    VP Collins
    British Journal of Cancer, 1997, 75 : 2 - 8
  • [37] CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma.
    Templier, I.
    Charles, J.
    Combe, M. -C.
    De Paillerets, B. Bressac
    Leroux, D.
    Leccia, M. -T.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2006, 133 (10): : 777 - 780
  • [38] Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
    Cottone, Lucia
    Eden, Nadia
    Usher, Inga
    Lombard, Patrick
    Ye, Hongtao
    Ligammari, Lorena
    Lindsay, Daniel
    Brandner, Sebastian
    Pizem, Joze
    Pillay, Nischalan
    Tirabosco, Roberto
    Amary, Fernanda
    Flanagan, Adrienne M.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (02): : 113 - 123
  • [39] MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, Hanim I.
    Vinocha, Anjali
    Dono, Antonio
    Ogunbona, Oluwaseun Basit
    Toruner, Gokce A.
    Aung, Phyu P.
    Kamiya Matsuoka, Carlos
    Esquenazi, Yoshua
    Demonte, Franco
    Ballester, Leomar Y.
    CANCERS, 2024, 16 (19)
  • [40] Analysis on point mutation of the cdkn2/p16 gene in lung cancer
    Su, Changqing
    Ye, Yukun
    Wang, Dong
    Cao, Xiangrong
    Li, Shufeng
    Shan, Xiangnian
    Chinese Journal of Medical Genetics, 2002, 19 (01) : 37 - 40
12345